Subcutaneous MabThera (Rituxan) approved for ... - CLL Support

CLL Support

22,368 members38,474 posts

Subcutaneous MabThera (Rituxan) approved for NHL, CLL should follow... New formulation cuts treatment time to five minutes.

5 Replies

You need to be a member of this community to see this post.

Read more about...
5 Replies

You need to be a member of this community to see hidden responses.

You may also like...

new NICE approved CLL treatment zanubrutinib TA931

Canadian Study...treatment increases risk of secondary cancers in CLL

compared with untreated follicular lymphoma patients, untreated CLL patients had a two-fold...

Ibrutinib Slow but steady foreward movement.

lymphocytic leukemia (CLL)/small lymphocytic lymphoma(SLL) and mantle cell lymphoma (MCL)....

Survey for CLL patients having taken Venetoclax or Acalabrutinib

CLL/SLL Patient Survey If you have CLL or SLL and have been treated with the following therapies,...

Do you know if your CLL is familial or sporadic?

CLL is an uncommon cancer, patients who have at least one relative with CLL are considered...